LH logo

Labcorp Holdings Inc. (LH)

$368.24

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on LH

Market cap

$29.90B

EPS

12.19

P/E ratio

25.8

Price to sales

1.76

Dividend yield

0.782%

Beta

0.841143

Price on LH

Previous close

$372.46

Today's open

$372

Day's range

$368.07 - $374

52 week range

$245 - $375.10

Profile about LH

CEO

Adam H. Schechter

Employees

71000

Headquarters

Burlington, NC

Exchange

New York Stock Exchange

Shares outstanding

81200000

Issue type

Common Stock

LH industries and sectors

Healthcare

Medical Diagnostics & Screening

News on LH

OTraces Selects Labcorp to Perform Biomarker Testing for Florida Department of Health–Funded Prostate Cancer Study

DEERFIELD BEACH, Fla., Nov. 18, 2026 (GLOBE NEWSWIRE) -- OTraces, Inc., a diagnostics company developing proteomic blood tests for early cancer detection, today announced that it has selected Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, to perform reference laboratory testing for its Florida Department of Health–funded clinical trial evaluating the OTraces blood-based prostate cancer diagnostic platform.

news source

GlobeNewsWire • 9 hours ago

news preview

Worried investors are paying up for these stocks — some with up to 49% upside, analysts say

Defensive sectors have beaten the S&P 500 by a wide margin in recent months, even though they are priced much higher relative to earnings estimates than the index.

news source

Market Watch • 6 hours ago

news preview

Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo Fleury

Expansion will bring clinical trial services closer to research sites and patients while supporting global studies BURLINGTON, N.C., Nov. 17, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with Grupo Fleury, one of Brazil's leading healthcare and diagnostic groups, with extensive laboratory infrastructure, scientific expertise and a strong presence across the Brazil healthcare ecosystem, to expand clinical trial operations in the country.

news source

PRNewsWire • Nov 17, 2026

news preview

Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Nov 17, 2026

news preview

Labcorp's Lab Growth Surges as $125 Million Reimbursement Risk Looms

Labcorp NYSE: LH Chief Financial Officer Julia Wang said strength in the company's central laboratory business and diagnostic testing helped drive third-quarter growth, while management prepares for a potential reduction in government reimbursement rates in 2027.

news source

MarketBeat • Nov 13, 2026

news preview

Labcorp: 3 Key Takeaways for Long-Term Investors

Revenue grew 7% to $3.8 billion in the third quarter. Proposed Medicare fee schedule changes present a $125 million potential impact.

news source

The Motley Fool • Nov 13, 2026

news preview

Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript

Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript

news source

Seeking Alpha • Nov 11, 2026

news preview

Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?

LH's specialty testing growth, AI-driven efficiencies and expanding margins support its outlook, though currency pressures and competition pose risks.

news source

Zacks Investment Research • Nov 10, 2026

news preview

Labcorp Holdings (LH) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Labcorp to Speak at the UBS Global Healthcare Conference

BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10 at 8:45 a.m.

news source

PRNewsWire • Nov 4, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Labcorp Holdings Inc.

Open an M1 investment account to buy and sell Labcorp Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in LH on M1